Member Info for EmeraldCarrots

Must admit years ago I saw with 1 share the bid higher than the ask. Could not buy for some reason........ LOL!

I keep seeing oddities with the bid/ask. E.G my gut tells me the sp should now be 3.1/3.15, yet it says 3.05/3.15. Anyone watching the trades see what I mean?

--------------

There are loads of trades going through @ 3.11p (sells) and 3.14 (buys), yet the bid says 3.05, not 3.1p???

I keep seeing oddities with the bid/ask. E.G my gut tells me the sp should now be 3.1/3.15, yet it says 3.05/3.15. Anyone watching the trades see what I mean?

Are, or will be the markets for Genedrives 2 machines. The key is simply the speed of result, is it not?

1. Stroke victims. Genedrive CYP2C19. On diagnosis the medic needs to quickly know whether they can use Clopidogrel blood thinner or not as some people are resistant to it. Sending off to a lab and waiting many hours or even days to find out is simply not practical. The Genedrive CYP2C19 gives an answer in about an hour.

2. Babies suspected of having sepsis. Genedrive® MT-RNR1 ID. On diagnosis the medic needs to quickly know whether they can use the cheap commonly used antibiotic or not. This antibiotic can occasionally cause total deafness to susceptible babies. Sending off to a lab and waiting many hours or even days to find out is simply not practical. The Genedrive® MT-RNR1 ID gives an answer in about an hour.

Investors on a big winner here, I think!

All IMHO.

Stu485.

You are the one deliberately missing the point.

Lab tests are no good as you have to get the sample to the lab, then it's tested, then couriered back. Several hours or a few days?? You cannot be serious posting this complete rubbish. Anyone with a brain cell can see that using a lab for an urgent test is a non-started. Genedrive's machine can do the tests in about an hour. I can't believe what rubbish is posted on here!

All IMHO.

Thanks. So the machine that you can test babies with to see if they might loose their hearing due to a bad reaction to the commonly used antibiotic is £5,994.00 (that is what the spreadsheet says now).

Printer and charging cable £480.00.

"Upfront cost" to NHS £6,474.00.

Do you have the same information for the Genecrive CYP2C19-ID Kit (stroke one)?

Exciting times for Genedrive, at long last!

Would be nice to know the costs.

Genedrive MT-RNR1 (hearing one) = £

Genecrive CYP2C19-ID Kit (stroke one) = £

Really interested to know.

Costs? Please post proof.

Energency department will need Genedrive's CYP2C19-ID Kit so they can quickly administer the right drug to stroke victims. Not sure how many hospitals have an a&e dept? I know there are over 1,500 hospitals though.

Outrageous relentless monthly cash burn of £400K to £600k every single month!!!"

==================

As the sales of both the machines increase, as they will now they are BOTH cleared for use in the NHS the cash burn will obviously decline. Looking back at the RNS to do with the Genedrive MT-RNR1 (the other machine) on 24th May it said:-

"five UK hospitals in the Greater Manchester region as they progress towards the sustained deployment in clinical practice in these Neonatal Intensive Care Units ("NICU").

The total value of the orders is in excess of £100,000."

So that machine costs about £20,000 each it seems.

If we assume the CYP2C19-ID Kit is a similar cost, is they can shift say 100 of them in the first 3 months that would be 100 x £20,000.00 = £2 million. No-one knows what the sales will be of course. I suspect the CYP2C19-ID Kit (to do with strokes) will absolutely rocket.

All IMHO.

Slacker246.

"They will do what NICE recommends and it's as simple as that!!

Risk vs benefit vs cost".

================

I agree. The document is guidance.:-

Point-of-care testing

1.3 Use the Genedrive CYP2C19 ID Kit point-of-care test for CYP2C19 genotype testing when laboratory-based testing is not available.

================

So, the doctor has the decision. Do they use the small photocopier sized machine to get the result in about an hour, or do they tie up a bed for hours if not days waiting for the result of a lab test and risk the patient having another stroke any dying? I know what any normal person would do!

All IMHO.

Slacker246.

The guidelines say:-

Point-of-care testing

1.3 Use the Genedrive CYP2C19 ID Kit point-of-care test for CYP2C19 genotype testing when laboratory-based testing is not available.

==================

In practice do you honestly think a Doctor is going to go through all the hassle of sending off for a lab test that takes many hours if not days when the patient is there on the bed ready to receive the right drug? Or are they going to use the Genedrive machine which gives the result in about 1 hour? Hmmm.... Scratchy head time?? I don't know what your motivation is, but your arguments are fatally flawed. GDR is likely to receive an off to buy is out @ say 6 to 8p a share at the moment. Are you worried? I think you need a re-think.

All IMHO.

Buying Genedrives CYP2C19-ID Kit is a complete no brainer. The machine analyses a person’s DNA from a mouth swab to find out if they are resistant to the best stroke follow up drug or not IN ABOUT AN HOUR. Again ***in about an hour***. The same sort of test using the lab route takes several hours and sometimes several days. You would have to be a complete idiot to not understand how important this is. What if the patient DIES from another stroke (what the follow-on drug tries to prevent) while waiting for the lab result? How can anyone not understand that?? Sales of this machine are going to ROCKET.

https://www.lse.co.uk/rns/GDR/nice-recommends-cyp2c19-id-kit-in-final-guidance-y8oukoeel6mfuuv.html

https://www.lse.co.uk/rns/GDR/first-uk-commercial-sales-of-the-cyp2c19-id-kit-4pr6ralute9tsur.html

All IMHO.

Buying Genedrives CYP2C19-ID Kit is a complete no brainer. The machine analyses a person’s DNA from a mouth swab to find out if they are resistant to the best stroke follow up drug on not IN ABOUT AN HOUR. Again ***in about an hour***. The same sort of test using the lab route takes several hours and sometimes several days. You would have to be a complete idiot to not understand how important this is. What is the patient DIES from another stroke (what the follow-on drug tries to prevent) while waiting for the lab result? How can anyone not understand that?? Sales of this machine are going to ROCKET.

https://www.lse.co.uk/rns/GDR/nice-recommends-cyp2c19-id-kit-in-final-guidance-y8oukoeel6mfuuv.html

https://www.lse.co.uk/rns/GDR/first-uk-commercial-sales-of-the-cyp2c19-id-kit-4pr6ralute9tsur.html

All IMHO.

Slacker246.

There are 543,141,481 shares issued, so what?

3% would be 16,294,245 shares.

We will find out in the next several days if the recent excellent news has prompted a more major investor to get involved and so issue a TR-1. 2 machines now cleared for use in the whole of the UK's NHS, one of them, so far, being put forward for FDA approval in the USA. No doubt the other one will follow. I suspect the Directors will be buying soon too as all news is likely to be in public now.

Compared to 5 months ago the future of GDR is now looking good. Investors will be looking.

All IMHO.

Expected soon here IMHO.

Popeye62

"Oh EmeraldCarrots & Porky9 - You really are naughty and misleading rampers. There's no stake building going on here!!! That's just a blatant ramp. If any institution wanted a stake, they had the opportunity in the raise at 1.5p.".

========================

Utter rubbish.

When the cash raise was done all GDR had was the pilot study of the Genedrive® MT-RNR1 ID Kit (the hearing one) in the NHS and the CYP2C19-ID Kit in development.

Since then, NICE have recommended the CYP2C19-ID Kit in final guidance (the stroke one). That is massive news (not a pilot study). Also, they have got Breakthrough Device Designation from the U.S. FDA for the MT-RNR1 ID Kit.

Two 3-to-4-fold better prospects I'd say.

All IMHO.

Your statement is Impossible to know, and you know that. They would have to hold 3% or more.

Liar was a bit strong Popeye62, sorry.

"Not one solitary institution owns a single share in Genedrive"

Your statement is Impossible to know, and you know that. They would have to hold 3% or more. Liar.

"Not one solitary institution owns a single share in Genedrive"

Someone should be on it! £17m market cap. 2 machines cleared for use in the NHS. FDA approval applied for for 1 and will be applied for for the other. Bonkers sp. Sp will absolutely take off at some point.

All IMHO.